Effect of K-877, a potent and selective PPAR alpha modulator (SPPARM alpha), on postprandial hyperlipidemia in dyslipidemic patients: a randomized cross-over study
Event:
ESC Congress 2016
Topic:
Drug therapy
Session:
Lipid-lowering agents - New perspectives
